Organoids And Spheroids Market - Forecast(2023 - 2028)

Report Code: HCR 1390 Report Format: PDF + Excel

Organoids and Spheroids Market Overview

Organoids and Spheroids market size was estimated at $508.45 million in 2020, growing at a CAGR of 23.76% during the forecast period 2021-2026. Organoids and spheroids are 3D cell cultures. Spheroids are made from cancer cell lines or tumour biopsies in ultra-low attachment plates as freely floating cell aggregates. Organoids are made from embryonic stem cells, induced pluripotent stem cells implanted in an ECM hydrogel matrix and they can self-assemble into miniature copies of the host organ when given a scaffolding environment, making them ideal for 3D cell investigations. Organoids are a complex assemblage of cluster of cells that are mostly derived from the bladder, liver, and stomach. Increasing technological advancement in 3D spheroid technology is one of the major factor driving the growth of the market. Increasing the use of organoid-based research models in developed countries. is set to further enhance the overall market development of the Organoids and Spheroids Market for the period 2021-2026.

Report Coverage

The report: “Organoids and Spheroids Market Forecast (2021-2026)”, by Industry ARC, covers an in-depth analysis of the following segments of the Organoids and Spheroids Market.
By Organoid Type: Neural Organoids, Hepatic Organoids, Intestinal Organoids and Others.
By Spheroid Type: Multicellular Tumor Spheroids, Neurospheres, Mammospheres, Hepatospheres and Others.
By Application: Developmental Biology, Regenerative Medicine, Personalized Medicine, Disease Pathology Studies and Drug Toxicity and Efficacy Testing. 
By End-User: Biotechnology & Pharmaceutical Industries, Academic and Research Institutes and Hospitals and Diagnostic Centers.
By Geography: North America (U.S., Canada, Mexico), Europe (Germany, U.K., France, Italy, Spain, Russia, and Rest of Europe), Asia Pacific (China, Japan India, South Korea, Australia, and New Zealand, and Rest of Asia Pacific), South America (Brazil, Argentina, and Rest of South America), and Rest of the World (Middle East, and Africa)

Key Takeaways

  • North America dominated the Organoids and Spheroids Market in 2020 owing to increasing investment by key players in this region. The Organoids and Spheroids Market scope for different regions will be provided in the final report.
  • Growing technological advancement and research & development activities by market players is set to aid the market growth of the Organoids and Spheroids Market report.
  • Detailed analysis of the Strength, Weakness, and Opportunities of the prominent players operating in the market will be provided in the Organoids and Spheroids Market report.
  • High price for research and development is poised to create the hurdles for the Organoids and Spheroids Market.

Organoids and Spheroids Market Revenue Share, By Geography, 2020(%)

Organoids and Spheroids Market

For more details on this report - Request for Sample

Organoids and Spheroids Market Segment Analysis – By Application

Based on application, market for Organoids and Spheroids is categorized in Developmental Biology, Regenerative Medicine, Personalized Medicine, Disease Pathology Studies and Drug Toxicity and Efficacy Testing. Developmental Biology segment in Organoids and Spheroids market held the largest share. The use of organoid and spheroid culture systems in developmental biology is increased. Organoid biology offers a great opportunity to the test the fundamentals of human developmental biology discovered through traditional methods thereby increasing Organoids and Spheroids market. However, Regenerative Medicine is estimated to register higher CAGR of 24.56% during the forecast period 2021-2026 owing to increasing adoption of regenerative medicine products as it provide faster recovery.

Organoids and Spheroids Market Segment Analysis – By End-User

On the basis of end user market for Organoids and Spheroids is categorized in Biotechnology & Pharmaceutical Industries, Academic and Research Institutes and Hospitals and Diagnostic Centers. Biotechnology & Pharmaceutical Industries segment in Organoids and Spheroids market held the largest share. Organoids and spheroids are commonly used in the development of drugs by biotechnology and pharmaceutical companies. Growing collaborations and strategic alliances among large players thereby increasing Organoids and Spheroids market. However, Hospitals and Diagnostic Centers is estimated to register higher CAGR of 24.68% during the forecast period 2021-2026 owing to increasing government support and funding by government for research and development. 

Organoids and Spheroids Market Segment Analysis – By Geography

North America dominated the Organoids and Spheroids market with a major share of 43.28% in 2020. This is attributed to growing usage of organoid-based research models in biotechnology sector in this region. Furthermore, presence of funding bodies in this region which are contributing to the growth of the market in this region.

However, Asia Pacific is estimated to grow at a higher CAGR during the forecast period 2021-2026 owing to rising research and development in stem cells in this region. Increasing presence of key players in this region is also increasing the growth of the market in this region. 

Organoids and Spheroids Market Drivers

Increasing Technological Advancement in 3D Spheroid Technology.

Increasing technological advancement and innovation in 3D spheroid technology across the globe is increasing the growth of the Organoids and Spheroids Market. For instance, AMS Biotechnology (AMSBIO) launched Cultrex Organoid Progenitor Cells which can be improved utilising a variety of extracellular matrices, allowing researchers to influence cellular activity by altering the culture micro-environment. As a result, spheroids created using this technique are utilised to represent cell invasion from tumour spheroids is also practiced to increase the growth of the Organoids and Spheroids market during the forecast period 2021-2026. 

Increasing Demand of  Organoid Cultures in Drug Development Process

Increasing demand of organoid cultures in the process of drug development is increasing the growth of the Organoids and Spheroids market. Rising research and development activities by key players for screening drugs during clinical trial as clinical trial focus on safety of drugs thereby increasing the growth of the Organoids and Spheroids Market during the forecast period 2021-2026.

Organoids and Spheroids Market Challenges

High Cost 

Major factor that is set to impede the growth of the Organoids and Spheroids market is high of cost of research and dveleopment. Another factor which hamper the growth of market is lack of skilled professional. 

Organoids and Spheroids Market Landscape

Product launches, mergers and acquisitions, joint ventures, and R&D activities are key strategies adopted by players in the Organoids and Spheroids Market. In 2020, the Organoids and Spheroids Market share is consolidated by the top ten players present in the market.
Top 10 companies
  1. 3D Biotek LLC.
  2. 3D Biomatrix
  3. Thermo Fisher Scientific, Inc
  4. STEMCELL Technologies Inc
  5. AMS Biotechnology
  6. Corning Incorporated
  7. Merck KGaA
  8. Lonza
  9. Prellis Biologics
  10. Greiner Bio-One

Organoids and Spheroids Market Development: 

  • In March 2020, UPM Biomedicals partnered with Nichirei Biosciences Inc. to provide researchers in Japan with the full range of UPM cell cultures products. 

Relevant Titles:

Report Code: HCR 0014

Report Code: HCR 0027

For more Lifesciences and Healthcare related reports, please click here


1. Organoids and Spheroids Market - Overview
    1.1 Definitions and Scope
2. Organoids and Spheroids Market - Executive Summary
    2.1 Market Revenue and Key Trends
    2.2 Key trends by Organoid type
    2.3 Key trends by Spheroid type
    2.4 Key trends by Application
    2.5 Key trends by End-User
    2.6 Key trends by Geography
3. Organoids and Spheroids Market – Comparative Analysis
    3.1 Product Benchmarking – Key Companies
    3.2 Financial Analysis – Key Companies
    3.3 Market Value Split by Key Companies
    3.4 Patent Analysis
    3.5 Pricing Analysis- Average Selling Price
4. Organoids and Spheroids Market - Startup Companies Scenario Premium
    4.1 Key Startup Company Analysis by
        4.1.1 Investment
        4.1.2 Revenue
        4.1.3 Venture Capital and Funding Scenario
5. Organoids and Spheroids Market – Industry Market Entry Scenario Premium Premium
    5.1 Regulatory Framework Overview
    5.2 New Business and Ease of Doing business index
    5.3 Case Studies of Successful Ventures
6. Organoids and Spheroids Market Forces
    6.1 Market Drivers
    6.2 Market Constraints/Challenges
    6.3 Porters five force model
        6.3.1 Bargaining power of suppliers
        6.3.2 Bargaining powers of customers
        6.3.3 Threat of new entrants
        6.3.4 Rivalry among existing players
        6.3.5 Threat of substitutes
7. Organoids and Spheroids Market – Strategic Analysis
    7.1 Value Chain Analysis
    7.2 Opportunities Analysis
    7.3 Market Life Cycle
8. Organoids and Spheroids Market – By Organoid type (Market Size –$Million/$Billion)
    8.1 Neural Organoids
    8.2 Hepatic Organoids
    8.3 Intestinal Organoids
    8.4 Others
9. Organoids and Spheroids Market - By Spheroid Type (Market Size –$Million/$Billion)
    9.1 Multicellular Tumor Spheroids
    9.2 Neurospheres
    9.3 Mammospheres
    9.4 Hepatospheres
    9.5 Others
10. Organoids and Spheroids Market - By Application(Market Size –$Million/$Billion)
    10.1 Developmental Biology
    10.2 Regenerative Medicine
    10.3 Personalized Medicine
    10.4 Disease Pathology Studies
    10.5 Drug Toxicity and Efficacy Testing
11. Organoids and Spheroids Market - By End User(Market Size –$Million/$Billion)
    11.1 Biotechnology & Pharmaceutical Industries
    11.2 Academic and Research Institutes
    11.3 Hospitals and Diagnostic Centers 
12. Organoids and Spheroids Market - By Geography(Market Size –$Million/$Billion)
    12.1 North America
        12.1.1 U.S.
        12.1.2 Mexico
        12.1.3 Canada
    12.2 Europe
        12.2.1 U.K.
        12.2.2 France
        12.2.3 Germany
        12.2.4 Italy
        12.2.5 Spain
        12.2.6 Russia
        12.2.7 Rest of Europe
    12.3 Asia Pacific
        12.3.1 China
        12.3.2 India
        12.3.3 Japan
        12.3.4 South Korea
        12.3.5 Australia & New Zealand
        12.3.6 Rest of APAC
    12.4 South America
        12.4.1 Brazil
        12.4.2 Argentina
        12.4.3 Others
    12.5 Rest of the World
        12.5.1 Middle East
        12.5.2 Africa
13. Organoids and Spheroids Market - Entropy
14. Organoids and Spheroids Market – Industry/Segment Competition Landscape Premium
    14.1 Market Share Analysis
        14.1.1 Global Market Share – Key Companies
        14.1.2 Market Share by Region – Key companies
        14.1.3 Market Share by Countries – Key Companies
        14.1.4 Competition Matrix
        14.1.5 Best Practices for Companies
15. Organoids and Spheroids Market – Key Company List by Country Premium Premium
16. Organoids and Spheroids Market Company Analysis Analysis(Company Revenue, Product, M&A, Developments)
    16.1 Company 1
    16.2 Company 2
    16.3 Company 3
    16.4 Company 4
    16.5 Company 5
    16.6 Company 6
    16.7 Company 7
    16.8 Company 8
    16.9 Company 9
    16.10 Company 10
 "*Financials for private companies would be provided on a best efforts basis”.